Tango Therapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- April 10, 2020
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $60,000,000
Company Info
- Company Description
- Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of targeted therapies to people with cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at driver genes in cancer.
- Market
- Cancer therapies
- Location
- Cambridge, MA, USA
- Coinvestors
- Boxer Capital, Casdin Capital, Cormorant Asset Management